I believe many of us received calls, but I haven’t received a second call. This was discussed a month or more ago. The tone of all posters at the time was a resounding NO, and most people gave their opinions on why Pfizer’s takeover bid was doomed to fail at the pathetic price at the time.
If anyone rings me again I have the extra ammunition of FDA of SleepCheck, Medgate’s extension and expansion into Germany, extra patents, and much greater focus and interest from a very wide professional population.
Hold tight everyone, this disrupter is too good to sell out for peanuts.
RAP Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held